Phase 1/1b trial of fruquintinib in patients with advanced solid tumors: Preliminary results of the dose expansion cohorts in refractory metastatic colorectal cancer

被引：1
|
作者：
Dasari, Arvind
Hubbard, Joleen M.
Eng, Cathy
Yeckes-Rodin, Heather
Ukrainskyj, Stacey M.
Yang, Zhao
Schelman, William R.
Kania, Marek K.
Bekaii-Saab, Tanios S.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Mayo Clin, Rochester, MN USA
[3] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[4] Cleveland Clin Florida, Port St Lucie, FL USA
[5] HUTCHMED Int, Shanghai, Peoples R China
[6] HUTCHMED Int, Florham Pk, NJ USA
[7] Mayo Clin, Div Hematol Oncol, Phoenix, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.093
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
93
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Preliminary pharmacodynamic evaluation of AU-007 in phase 1 dose escalation trial in patients with advanced solid tumors
    Wyant, Timothy
    Frentzas, Sophia
    Ahern, Elizabeth
    Weickhardt, Andrew
    Haydon, Andrew
    Powderly, John
    Rasco, Drew
    McKean, Meredith
    De Souza, Paul
    Tang, Jenny
    Richards, Lori
    Knckerbocker, Aron
    Ofran, Yanay
    Amit, Inbar
    Vasselli, James
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [32] Phase 1b trial of cirmtuzumab and paclitaxel for locally advanced, unresectable and metastatic breast cancer
    Shatsky, Rebecca A.
    Schwab, Richard B.
    Helsten, Teresa L.
    Pittman, Emily I.
    Chen, Ruifeng
    Breitmeyer, James B.
    Jamieson, Catriona H. M.
    Kipps, Thomas J.
    Parker, Barbara A.
    CANCER RESEARCH, 2020, 80 (04)
  • [33] A phase 1b multitumor cohort study of cabozantinib plus atezolizumab in advanced solid tumors (COSMIC-021): Results of the colorectal cancer cohort
    Abrams, Thomas Adam
    Kazmi, Syed Mohammad Ali
    Winer, Ira Seth
    Subbiah, Vivek
    Falchook, Gerald Steven
    Reilley, Matthew
    Kunk, Paul Raymond
    Goel, Sanjay
    Garrido-Laguna, Ignacio
    Kochenderfer, Mark D.
    Werneke, Scott
    Andrianova, Lana
    Sudhagoni, Ramu
    Paulson, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [34] Results from a dose escalation phase 1b study of palbociclib and avelumab in advanced breast cancer in the PAveMenT Trial
    Okines, Alicia F.
    Moghadam, Houman
    Sparks, Laura
    Mohammed, Kabir
    Dunne, Kathryn
    Nerurkar, Ashutosh
    Osin, Peter
    Swift, Claire
    Sardinha, Ruth
    Turner, Nicholas
    CANCER RESEARCH, 2023, 83 (05)
  • [35] Eganelisib, a First-in-Class PI3Kg Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 Trial
    Hong, David S.
    Postow, Michael
    Chmielowski, Bartosz
    Sullivan, Ryan
    Patnaik, Amita
    Cohen, Ezra E. W.
    Shapiro, Geoffrey
    Steuer, Conor
    Gutierrez, Martin
    Yeckes-Rodin, Heather
    Ilaria Jr, Robert
    O'Connell, Brenda
    Peng, Joanna
    Peng, Guangbin
    Zizlsperger, Nora
    Tolcher, Anthony
    Wolchok, Jedd D.
    CLINICAL CANCER RESEARCH, 2023, 29 (12) : 2210 - 2219
  • [36] Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial
    Keilholz, Ulrich
    Mehnert, Janice M.
    Bauer, Sebastian
    Bourgeois, Hugues
    Patel, Manish R.
    Gravenor, Donald
    Nemunaitis, John J.
    Taylor, Matthew H.
    Wyrwicz, Lucjan
    Lee, Keun-Wook
    Kasturi, Vijay
    Chin, Kevin
    von Heydebreck, Anja
    Gulley, James L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [37] A phase 1b/2 study of ramucirumab in combination with emibetuzumab in patients with advanced solid tumors
    Bendell, Johanna
    Fuchs, Charles
    Voss, Martin
    Bauer, Todd M.
    Choueiri, Toni K.
    Drilon, Alexander
    Thorn, Katharine
    Wijayawardana, Sameera
    Moser, Brian
    Urunuela, Arantxa
    Wacheck, Volker
    Harding, James J.
    CANCER RESEARCH, 2017, 77
  • [38] First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors
    Bauer, Todd
    Cho, Byong Chul
    Heist, Rebecca
    Bazhenova, Lyudmila
    Werner, Theresa
    Goel, Sanjay
    Kim, Dong-Wan
    Adkins, Douglas
    Carvajal, Richard D.
    Alva, Ajjai
    Eaton, Keith
    Wang, Judy
    Liu, Yong
    Yan, Xiaohong
    Christensen, Jamie
    Neuteboom, Saskia
    Chao, Richard
    Pant, Shubham
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (05) : 990 - 1000
  • [39] First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors
    Todd Bauer
    Byong Chul Cho
    Rebecca Heist
    Lyudmila Bazhenova
    Theresa Werner
    Sanjay Goel
    Dong-Wan Kim
    Douglas Adkins
    Richard D. Carvajal
    Ajjai Alva
    Keith Eaton
    Judy Wang
    Yong Liu
    Xiaohong Yan
    Jamie Christensen
    Saskia Neuteboom
    Richard Chao
    Shubham Pant
    Investigational New Drugs, 2022, 40 : 990 - 1000
  • [40] A phase 1/1b study of satraplatin (JM-216) in combination with docetaxel in patients with advanced solid tumors and metastatic castrate-resistant prostate cancer
    Cetnar, Jeremy
    Wilding, George
    McNeel, Douglas
    LoConte, Noelle K.
    McFarland, Thomas A.
    Eickhoff, Jens
    Liu, Glenn
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (04) : 436 - 441
12345